A Study of Mavacamten in Non-Obstructive Hypertrophic Cardiomyopathy
Condition(s):Cardiomyopathy, HypertrophicLast Updated:February 26, 2024Recruiting
Include Studies Not Open or Pending
Condition(s):Cardiomyopathy, HypertrophicLast Updated:February 26, 2024Recruiting
Condition(s):Cardiomyopathy, HypertrophicLast Updated:March 8, 2024Recruiting
Condition(s):Cardiomyopathy, HypertrophicLast Updated:February 7, 2024Recruiting
Condition(s):Cardiomyopathy, HypertrophicLast Updated:March 27, 2018Recruiting
Condition(s):Cardiomyopathy, HypertrophicLast Updated:February 28, 2024Recruiting
Condition(s):Hypertrophic CardiomyopathyLast Updated:June 1, 2023Recruiting
Condition(s):Hypertrophic CardiomyopathyLast Updated:March 16, 2023Recruiting
Condition(s):Hypertrophic CardiomyopathyLast Updated:September 21, 2022Recruiting
Condition(s):Hypertrophic CardiomyopathyLast Updated:November 29, 2022Recruiting
Condition(s):Hypertrophic CardiomyopathyLast Updated:December 26, 2023Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.